Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Avelumab, Palbociclib and Axitinib in in Treatment Naive Metastatic Clear Cell Renal Cell Carcinoma.

NCT05176288 is registered in ClinicalTrials.gov with Bradley A. McGregor, MD as lead sponsor.

NCT NCT05176288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05176288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Avelumab, Palbociclib and Axitinib in in Treatment Naive Metastatic Clear Cell Renal Cell Carcinoma.
Lead sponsor
Bradley A. McGregor, MD
Phase
Phase 2
Overall status
Withdrawn
Start date
May 31, 2024
Completion date
August 31, 2027
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced clear cell renal cell carcinoma